4DN Phase II (2020-2025)
PI Name | Institution |
---|---|
Yvonne Fondufe-Mittendorf, Ph.D. | Van Andel Institute |
Steve Henikoff, Ph.D. | Fred Hutchinson Cancer Center |
Thoru Pederson, Ph.D. | University of Massachusetts |
Abby Dernburg, Ph.D. | University of California Berkeley |
Carolyn Larabell, Ph.D. | University of California Berkeley |
Genevieve Almouzni, Ph.D. | Institut Curie, Paris, France |
4DN Phase I (2015-2020)
PI Name | Position | Institution |
---|---|---|
Marisa Bartolomei, Ph.D. | Professor of Cell and Developmental Biology | University of Pennsylvania, Perelman School of Medicine |
J. Michael Cerry, Ph.D. | Professor | Department of Genetics, Stanford University |
Tom Gingeras, Ph.D. | Professor | Cold Spring Harbor Laboratory |
Gary Karpen, Ph.D. | Senior Scientist | Division Director/Life Sciences Division Lawrence Berkeley National Laboratory Department of Energy |
Mathieu Lupien, Ph.D. | Scientist, Assistant Professor | Princess Margaret Cancer Centre / University Health Network University of Toronto, Department of Medical Biophysics |
Aviv Regev, Ph.D. | Professor of Biology | Core Member, Broad Institute Investigator, Howard Hughes Medical Institute Massachusetts Institute of Technology |
John Stamatoyannopoulos, M.D., D.Sc. | Associate Professor of Genome Sciences and of Medicine | University of Washington |
Michael Hawrylycz, Ph.D. | Investigator | Allen Institute |
Aaron Straight, Ph.D. | Associate Professor | Stanford University |
Jane Skok, Ph.D. | Professor | NYU School of Medicine |
Maria-Elena Torres-Padilla, Ph.D. | Group Leader | Helmholtz Zentrum München German Research Center for Environmental Health Institute of Epigenetics and Stem Cells |